| 1 Tag | -0.18% |
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Laura Cegala
HRO | Personalreferent | - | - |
David Dyer
PRN | Corporate Officer/Principal | - | 17.05.2021 |
| Datum | Initiiert | Typ | Hauptposition | Anzahl | % Marktkap. | Wichtigkeit |
|---|---|---|---|---|---|---|
| 16.09.24 | Emittentenverkauf | Verwaltungsratsmitglied | 36’713 | 0.0675% | ||
| 16.09.24 | Velan Capital Investment Management LP
| Emittentenverkauf | Unternehmen | 14’408’533 | 26.4940% | |
| 16.09.24 | Emittentenverkauf | Chief Marketing Officer & SVP | 1’232’852 | 2.2669% |
| % | % 5 Tage | Perf. 1 Jahr | Perf. 3 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -0.18% | - | - | 287 Mio. | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1’286 Mrd. | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688 Mrd. | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521 Mrd. | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386 Mrd. | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364 Mrd. | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302 Mrd. | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287 Mrd. | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252 Mrd. | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208 Mrd. | |
| Durchschnitt | +0.22% | +2.08% | +35.39% | +83.36% | 477 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.54% | +3.26% | +37.70% | +96.50% |
Beschäftigte
157
Sektor
Pharmazeutika
